Sustainable inflammatory bowel disease care

Inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis have developed as worldwide diseases. Although the advancement in therapeutics has temporarily reduced the rates of surgery, lifelong biologic therapy is economically unsustainable. The article “Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century” proposed numerous critical steps that were necessary in providing globally sustainable inflammatory bowel disease care. For instance, providing an early effective intervention to prevent long-term irreversible bowel damage and developing oral and targeted drugs that may be more sustainably delivered and safer. (Clin Gastroenterol Hepatol

. 2020 May;18(6):1252-1260. doi: 10.1016/j.cgh.2020.01.028. Epub 2020 Jan 31.)

Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Siew C. NG in Department of Medicine and Therapeutics, CUHK. Prof Ng’s research focuses on inflammatory bowel disease, fecal microbiota transplantation, colorectal cancer and endoscopy.